Plains Venture PartnersPlains Venture PartnersPlains Venture PartnersPlains Venture Partners
  • About
  • Portfolio
  • Team
  • Investor Login

Ascend BioVentures helps determine right path for health care discoveries

    Home News Ascend BioVentures helps determine right path for health care discoveries
    NextPrevious

    Ascend BioVentures helps determine right path for health care discoveries

    By sarah | News | 0 comment | 7 June, 2019 | 0

    By Scott Meacham
    Copyright © 2019, The Oklahoman

    It’s really difficult to invent new drug therapies.

    Research and development can take decades. Once a potential drug appears viable, testing for safety and efficacy adds more years. At every stage, risk of failure is extreme.

    Ascend BioVentures, a pharmaceutical accelerator company, helps Oklahoma’s early stage therapeutics advance through the riskiest early stages of development. A subsidiary of i2E, Ascend leverages the team at i2E for venture and investment services, as well as operational support.

    Leadership is critical to a venture like Ascend. With 10 years of professional leadership in the commercialization of early stage pharmaceutical therapeutics and diagnostics, Ascend CEO, Dr. Elaine Hamm understands this world inside and out.

    After earning her Ph.D. in microbiology from the University of Oklahoma and creating a technology that was licensed, Dr. Hamm worked at a startup as a chemist and then advanced to licensing newly created drugs to companies. Following a stint at i2E as a venture advisor, she held senior management positions at several early stage drug companies.

    “When asked to start Ascend, I knew I wanted to create something different,” Dr. Hamm said. “There are many models for accelerator programs; we wanted to find the right model for Oklahoma’s ecosystem. Ascend doesn’t have a one-size fits all approach.”

    Not every technology needs to become a company. Sometimes a new drug just needs a couple of experiments to move it forward, and Ascend can help with that. When a new company is formed, Ascend identifies the right path and the right leadership for each new drug. In this, Ascend’s diverse external Advisory Committee plays a key role. Advisory Committee members range from life science investor groups to executives and business develop leaders from both mid-sized and large pharmaceutical companies.

    “They ensure we select good technologies and that we provide industry validation,” said Dr. Hamm. “Members can be also involved downstream, from licensing, to investing, to serving in management or on the board of one of our startups. In fact, the CEO of our first company, Kirrhos Pharmaceuticals, was on the Advisory Committee.”

    The University of Oklahoma Health Sciences Center (OU), Presbyterian Health Foundation, and OMRF (Oklahoma Medical Research Foundation) are Ascend community partners and ready sources of new science. In the last six months, Ascend has reviewed more than 15 technologies from OU alone.

    “We provide the business case for a new drug. Everything from marketing information, recommendations on industry-based experiments, patent and regulatory strategies, and more,” Dr. Hamm said. “Sometimes Ascend and the Advisory Committee says no, and here’s why. That can be the most helpful advice.

    Ascend also seeks technology from across the U.S. and even the world.

    “There is never a shortage of technology,” said Dr. Hamm. “There are folks on the east and west coasts who are finding it hard to find support and raise funds. We are finding technologies that are being overlooked on the coasts that we can bring back to Oklahoma and develop here.”

    Ascend BioVentures is yet another example of Oklahoma’s leadership in biosciences and life sciences. It’s a key competitive advantage for our state.

    Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from the Oklahoma Center for the Advancement of Science and Technology. Contact Meacham at i2E_Comments@i2E.org

     

     

    Ascend BioVentures, Elaine Hamm, Scott Meacham

    Related Post

    • Norman’s IMMY has global impact, despite humble beginnings

      By sarah | 0 comment

      By Scott Meacham Copyright © 2019 The Oklahoman Sean and Scott Bauman, CEO and chief operating officer of biotechnology company IMMY, literally grew up in the family business. “There isn’t a job that my brotherRead more

    • Oklahoma’s bioscience prowess busy making a difference worldwide

      By sarah | 0 comment

      By Kevan Goff-ParkerCopyright © 2019 The Oklahoman Greater Oklahoma City Chamber Manager of Innovation and Entrepreneurship Evan Fay said he believes some people may be caught off-guard by Oklahoma’s growing bioscience prowess. He made hisRead more

    • OSU delegates share future bioscience innovations with leaders

      By sarah | 0 comment

      By Kevan Goff-Parker Copyright © 2019, The Oklahoman PHILADELPHIA — Three Oklahoma State University researchers this week have been connecting face-to-face with some of the world’s top bioscience companies during the 2019 BIO International ConventionRead more

    • Delegation Sharing Oklahoma’s Good News Bioscience Story at BIO International Convention

      By sarah | 0 comment

      By Kevan Goff-Parker Copyright ©2019, The Oklahoman PHILADELPHIA — More than 40 Oklahoma bioscience and industry experts from a wide array of fields are busy telling global industry leaders about the state’s successes in theRead more

    • Remembering those who gave their all in service to our country

      By sarah | 0 comment

      By Scott Meacham Copyright © 2019 The Oklahoman Each year on Memorial Day, we honor the military men and women who gave their lives serving our country. Memorial Day is so much more than justRead more

    Leave a Comment

    You must be logged in to post a comment.

    NextPrevious

    Investor Login

    • Disclaimer & Disclosure

    Oklahoma City Location

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305

    Tulsa Location

    100 S Cincinnati Ave, 5th Floor, Suite 514
    Tulsa, OK 74103
    PHONE 918/582-5592

    • Disclaimer & Disclosure
    Copyright 2022 i2E, Inc. | All Rights Reserved
    • About
    • Portfolio
    • Team
    • Funds
    • Investor Login
    Plains Venture Partners